Loading...
XTSX
VM
Market cap20mUSD
Aug 01, Last price  
0.17CAD
1D
-2.86%
1Q
-10.53%
IPO
70.00%
Name

Voyageur Pharmaceuticals Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
22.39%
Rev. gr., 5y
%
Revenues
0k
Net income
-1m
L-20.21%
0-85,518-45,327-94,460-1,482-52,323-670,752-555,860-552,293-1,139,422-2,051,467-1,753,894-1,399,469
CFO
-302k
L-69.50%
-28,1872,317-54,728-23,657-70,649-35,070-624,237-490,452-637,807-272,194-1,654,285-1,718,754-991,252-302,289

Profile

Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.
URL
https://voyageurpharmaceuticals.ca/
IPO date
May 18, 2012
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑112023‑112022‑112021‑112020‑112019‑112018‑112017‑112016‑122015‑12
Income
Revenues
Cost of revenue
659
1,752
Unusual Expense (Income)
NOPBT
(659)
(1,752)
NOPBT Margin
Operating Taxes
2
Tax Rate
NOPAT
(659)
(1,754)
Net income
(1,399)
-20.21%
(1,754)
-14.51%
Dividends
Dividend yield
Proceeds from repurchase of equity
656
1,200
1,157
BB yield
-22.99%
-15.33%
Debt
Debt current
Long-term debt
40
40
26
Deferred revenue
Other long-term liabilities
14
14
14
Net debt
(126)
24
(20)
Cash flow
Cash from operating activities
(302)
(991)
(1,719)
CAPEX
(283)
Cash from investing activities
(166)
(175)
(274)
Cash from financing activities
632
1,136
1,211
FCF
950
(609)
(1,578)
Balance
Cash
166
2
32
Long term investments
14
14
Excess cash
166
16
46
Stockholders' equity
(1,676)
(426)
(177)
Invested Capital
2,179
1,916
1,681
ROIC
ROCE
EV
Common stock shares outstanding
130,504
107,826
Price
0.07
62.50%
0.04
-42.86%
0.07
-22.22%
Market cap
5,220
-30.84%
7,548
-11.42%
EV
5,244
7,528
EBITDA
2
(657)
(1,743)
EV/EBITDA
Interest
Interest/NOPBT